GlassScriptPhysician profile
Daniel S Husted
NPI 1174543573
$878,038.50
in general payments reported to CMS, 2019-2025
15 companies · $5,454 in 2025
The $5,454 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243K · 2020: $302K · 2021: $218K · 2022: $98K · 2023: $3,626 · 2024: $8,374 · 2025: $5,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $17K · Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $17,112.46 |
| Food and Beverage | $341.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Republic Spine | $828,998.40 | 2019-2022 | |
| Precision Spine, INC. | $47,612.46 | 2021-2025 | |
| Si-Bone, INC. | $578.21 | 2019-2024 | |
| Atlas Spine, INC. | $323.09 | 2019 | |
| Abbott Laboratories | $161.55 | 2019-2025 | Eterna |
| Pfizer INC. | $77.88 | 2023-2025 | |
| Smith+Nephew, INC. | $57.88 | 2023-2025 | Journey II, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Davol INC. | $43.56 | 2025 | Avitene Ultrafoam |
| Southern Edge Orthopaedics, INC. | $36.98 | 2023 | |
| Stryker Corporation | $32.59 | 2025 | Mild Device Kit |
| Baxter Healthcare | $32.16 | 2020 | |
| Scilex Pharmaceuticals INC. | $30.92 | 2019 | |
| Orthofix Medical, INC. | $24.33 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.60 | 2022 | |
| Nevro Corp. | $11.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Husted listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.